| |
September 14, 2023 | 1:00 PM ET Over 50% of life sciences companies are doing patient finding. Are you? Register now to learn about patient finding best practices, use cases and common pitfalls. AIML is here. Be ready with Trinity Life Sciences. .png)
|
|
Today’s Big NewsAug 22, 2023 |
| By James Waldron After a six-month wait, Fulcrum Therapeutics’ sickle cell disease plans are back on track after the FDA lifted a hold on the biotech’s candidate. |
|
|
|
| Philadelphia, PA |  |
|
|
By Nick Paul Taylor The vultures are circling Aravive. Still reeling from a phase 3 flop, the cash-strapped biotech has “several weeks” to find a partner or funding—and is laying off 70% of its staff to preserve the little money it has left. |
By Nick Paul Taylor The long, ever-extending wait for midphase melanoma data is driving Ultimovacs to weigh its options. After slow disease progression drove another delay, the biotech revealed it will explore alternative data readout approaches if the event-driven trial continues to advance sluggishly toward its readout. |
By Helen Floersh A new class of drugs that combine artificial DNA structures with antibodies could make immunotherapies even more targeted—all you have to do is fold over and over again. |
|
Wednesday, August 30, 2023 | 1pm ET/ 10am PT Enzymes have long demonstrated their utility as a green alternative to metal-based catalysts, but the evolution time required can be significant. Join this webinar to learn about an extracellular strategy that reduces the evolution cycle and enables biocatalysis to be used much earlier in development. Register now. 
|
|
By Kevin Dunleavy,Max Bayer Already with an approval in hand for older adults, Pfizer’s Abrysvo has become the first vaccine for pregnant women to protect their newborns against respiratory syncytial virus (RSV). The FDA has signed off on Abrysvo for women who have been pregnant for 32 to 36 weeks. The shot affords protection to babies for the first six months of their lives. |
By Bram Sable-Smith, Kaiser Health News A Tulsa-based gas station chain is using its knowledge of how to serve customers and locate shops in easy-to-find spots to enter the urgent care industry, which has doubled in size over the past decade. Experts question how the explosion of convenient clinics will affect care costs and wait times. |
By Andrea Park “The market for kitted NGS-based companion diagnostics has not developed as we expected," Mike McMullen, Agilent’s president and CEO, told investors this month. |
By Angus Liu The FDA will hold an advisory committee meeting to discuss confirmatory trial data for Amgen's Lumakras in KRAS-mutated lung cancer. This comes after a bumpy stretch for the medicine since its debut in 2021. |
By Conor Hale PhenomeX was formed earlier this year after Berkeley Lights bought up IsoPlexis, a former Fierce Medtech Fierce 15 winner. |
By Noah Tong New draft guidance gives a blueprint for pharmacies to begin offering monthly payments on prescription drugs starting in 2025. |
Fierce podcasts Don’t miss an episode |
| This week on "Podnosis," we take a closer look at the challenges with new email policies, and the importance of diverse investors and founders. |
|
|---|
|
|
|
October 16-17 | Boston, MA Effectively drive collaboration between R&D, clinical and commercial teams to develop an appropriate timeline and practical approach to bringing new products to launch. Book you seat today and save $200! |
|
Whitepaper Learn how process liquids and buffers impact your total cost of ownership (TCO) and how outsourcing can revolutionize your approach, ensuring quality standards and improving productivity. Sponsored by: Thermo Fisher Scientific Process Liquid Preparation Services |
Whitepaper In oncology, traditional methods for determining sales force size & structure are no longer appropriate. This paper describes the multiple drivers of sales strategy in oncology markets today. Sponsored by: Blue Matter, strategic consultants in the life sciences |
Research Learn how the right chemical inventory strategy helped save a mid-size CDMO millions of dollars while securing a stable supply of products with just-in-time delivery. Sponsored by: Thermo Fisher Scientific Production Chemicals and Services |
| |
|
